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Insulin antagonized the lipolytic actions of epinephrine in rat epididymal dipocytes when the phosphodies- 
terase inhibitor, Ro 20-1724, was present. Adipocytes were depleted of functional CAMP by inhibiting aden- 
ylate cyclase with N6-phenylisopropyladenosine in th  presence of adenosine deaminase uch that Ro 20- 
1724 no longer stimulated lipolysis. The CAMP analogs I-thioisopropyl-CAMP or %thiomethyl-CAMP, 
which are resistant to phosphodiesterase hydrolysis, were subsequently added to bypass adenylate cyciase 
and phosphodiesterase ction. Under these conditions, insulin antagonized the lipolytic effects of these ana- 
logs, even in the presence ofRo 20- 1724. 
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1. INTRODUCTION are extremely dependent on the time and condi- 
tions of the incubation [ 11,161. 
It is generally accepted that one of the principal 
functions of insulin is to regulate fat mobilization 
by inhibiting the rate of lipolysis. Early studies 
demonstrated an insulin-mediated decrease of 
CAMP levels in adipose tissue stimulated with 
epinephrine [11. Subsequently, both insulin inhibi- 
tion of adenylate cyclase [2,3] and insulin stimula- 
tion of CAMP phosphodiesterase [4-71 have been 
reported. This led to the hypothesis that the an- 
tilipol~ic effect of insulin in adipose tissue could 
be fully accounted for by a decrease in CAMP con- 
centrations as a result of phosphodiesterase activa- 
tion and/or adenylate cyclase inhibition [8-l 11. 
However, several groups have challenged this 
mechanism based on the observation that insulin 
could inhibit lipolysis in the absence of any 
measurable changes in CAMP concentrations 
[12-161. In each case the evidence supporting these 
conclusions derive from CAMP measurements. 
These measurements can be misleading since they 
This paper presents a new approach not depen- 
dent on CAMP measurements to address the con- 
troversy surrounding the requirement of CAMP 
decreases for the antilipol~ic effects of insulin. By 
incubating adipocytes depleted of functional 
CAMP with phosphodiesterase resistant CAMP 
analogs, we present conditions where the an- 
tilipolytic effect of insulin is independent of both 
phosphodiesterase and adenylate cyclase action 
and therefore CAMP concentrations. 
2. MATERIALS AND METHODS 
Insulin was a gift from Dr Ron Chance of Eli 
Lilly Co. and Ro 20-1724 was a gift from Hoff- 
mann La Roche, 8-Thioisopropyl~AMP and 
Whiobenzyl-CAMP were purchased from ICN and 
N6-phenylisopropyladenosine (PIA) was from 
Boehringer Mannheim. All other reagents were ob- 
tained from Sigma. 
Abbreviation: Ro 20-1724, d-4-(3-butoxy~-methoxy- 
benzyl)-2-imidizolidione 
Adipocytes were prepared as in [ 171 from 
epidid~al fat pads of rats fed ad libitum. Ap- 
prox. 50 mg cells in 1 .O ml Krebs-Henseleit buffer 
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containing 1.2 mM CaC12, 2% bovine Serum 
albumin, and 280 mU/ml adenosine deaminase 
were incubated for 2 h at 37*C in plastic, 20-ml 
scintillation vials under an atmosphere of 
95%/5% 02 : CO2 yielding linear rates of glycerol 
release. The concentration af (NH&S04 added 
with adenosine deaminase had no effect on 
glycerol release. GIyceroi was measured in ceIf ex- 
tracts deproteinized with perchloric acid and 
neutralized with KOH according to 4181. 
3. RESULTS 
3.1. Effects of Ro 20-l 724 on insulin a~t~~~poiyf~~ 
effect 
To examine the role of phosph~i~sterase ac- 
tivation in the antilipolytic response of insulin, the 
effect of the phosphodiesterase inhibitor 
Ro 20-1724 on the insulin antagonism of 
epinephrin~“stimulated lip&is in adipocytes was 
determined. The ability of insulin to inhibit 
ep~neph~ne*stimulated glycerol release was un- 
changed by a maximally effective concentration of 
Ro 20-1724 (table 1). 
3.2. ~eplet~~~ of f~ncti~~a~ CAMP 
PIA, an inhibitor of adipocyte adenylate cyclase 
fl9]% was used to inhibit CAMP production in these 
cells. Authors in 1201 have demonstrated that 
lo-’ M PIA, in the presence of adenosine 
Table 1 
The effect of insulin on lipolysis stimulated by 
epinephrine and Ro 20-1724 
Effector 
No addition 
Epinephrine 
Epinephrine + 
Glycerol release (rrmol/g per h) 
- Insulin + Insulin 
1.21 Ifi 0.15 0.85 f: 0.09 
7.42 f 0.31 2.01 rt: 0.13 
Ro 20-1724 11.1 f 0.68 2.43 i 0.14 
Results are expressed as the means + SE of duplicates 
from 3 different cell preparations. ~ncentrations of 
effecters were: insulin, 1W” M; epinephrine, 5 x 
lo-’ M; Ra 20-1724, low4 M. Adipocytes were 
incubated for 2 h at 37T in medium containing 
280 mu/ml adenosine deaminase, as described in 
section 2 
8 
Table 2 
Depletion of functional CAMP in adipocytes 
Effector Glycerol release 
bmol/g per h) 
Control 1.16 f 0.09 
Ro 20- I724 2.61 I 0.10 
PIA 0.23 Yk 0*02 
PIA + Ro 20-1724 0.30 * 0.02 
Results are expressed as the means f SE of duplicates 
from 4 different cell preparations. The cancentration of 
PIA was lo-’ M and Ro 20-1724 lo-’ M. All other 
conditions were identical to those in fig.1 
deaminase to reduce extracelfular adenosine ac- 
cumulation, lowers intracellular CAMP levels to a 
point where adipocytes can be considered depleted 
of functional CAMP. In agreement with these 
authors, we observed that PIA markedly decreased 
basal lipolysis (table 2). Evidence that PIA effec- 
tively inhibited CAMP production was obtained by 
using the specific phosphodiesterase inhibitor 
Ro 20-1724 which, unlike the methylxanthines, is 
not an adenosine antagonist [21,22]. In the 
presence of PIA and adenusine deaminase, the 
stimulation of glycerol release by Ro 20-1724 was 
negligible compared to the large effect of 
Ro 20-1724 in the absence of PIA ([ZO]; table 2). In 
adipocytes incubated with PIA, exogenously add- 
ed CAMP analogs were still effective as lipolytic 
agents indicating that PIA did not interfere with 
the actions of CAMP at steps distal to CAMP 
generation (fig. 1). 
3.3, hstdin effect on 8-thiomefhyl-CAMP and 
To delineate the role of adenylate cyclase inhibi- 
tion in the antilipolytic actions of insulin, 
adipocytes were incubated with CAMP analogs 
which would bypass adenylate cyclase action. In- 
sulin antagonized the lipolytic effects of both 
8”thiomethyl-CAMP and 8-thioisopropyl-CAMP 
(fig,l), two analogs that permeate the plasma 
membrane 1231. Since these experiments were per- 
formed under conditions where the adipocytes 
were functionally depleted of intracellular CAMP, 
we con&de that insulin does not require adenylate 
cyclase inhibition for its antilipol~ic response. 
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Fig.1. The effect of insulin and Ro 20-1724 on lipolysis stimulated by (a) 8-thiomethyl-CAMP and (b) 8-thioisopropyl- 
CAMP. Adipocytes were incubated in the presence of lo-’ M PIA and 280 mu/ml adenosine deaminase as described 
in section 2 with either (a) 8-thiomethyl-CAMP (2.5 x 10m4 M) or (b) I-thioisopropyl-CAMP (2.5 x low4 M). Other 
effector concentrations were as in table 1. Results are expressed as the means f SE of duplicates from 4 different cell 
preparations. The control rate of glycerol release was 1.11 f 0.06 pmol/g per h. 
The analogs chosen, 8-thiomethyl-CAMP and 
8-thioisopropyl-CAMP, also have the feature of 
being resistant o hydrolysis by phosphodiesterase 
[25,26]. This was supported by the observation in 
vivo that phosphodiesterase inhibition by 
Ro 20-1724 had no effect on the rate of glycerol 
release (fig.1). The lipolytic effect of these two 
analogs cannot be due to phosphodiesterase inhibi- 
tion since, in these cells depleted of functional 
CAMP, phosphodiesterase inhibition alone did not 
stimulate lipolysis. Under these conditions, insulin 
antagonized the effects of either 8-thiomethyl- 
CAMP or 8-thioisopropyl-CAMP even in the 
presence of Ro 20-1724 (fig.1). Similar results were 
also obtained using another phosphodiesterase- 
resistant analog, 8-thiobenzyl-CAMP (not shown). 
These data clearly indicate that under these condi- 
tions the antilipolytic response of insulin is in- 
dependent of any effect on either phosphodies- 
terase or adenylate cyclase. 
4. DISCUSSION 
The antilipolytic effect of insulin has often been 
correlated with a decrease in CAMP concentrations 
in adipose tissue [1,8- 11,241. Although this is not 
an invariant finding [ 12- 161, some have proposed 
that this decrease in CAMP levels fully explains the 
antilipolytic actions of this hormone [8-l 11. Both 
sides of this controversy have used CAMP 
measurements as the basis for their conclusions. 
These measurements can be misleading since they 
9 
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are extremely dependent on experimental condi- 
tions. Since the spike rise in the concentration of 
CAMP is the important parameter for activation of 
the CAMP-de~ndent protein kinase and therefore 
lipolysis, time points for CAMP measurements 
must be chosen carefully. The possibility that 
CAMP may be sequestered or compartmentalized 
further complicates these measurements [27,28]. 
Differences in cell density, the pre-incubation con- 
ditions of adipocytes, and insulin concentrations 
have all been shown to influence the relationship 
between the antilipolytic effect of insulin and in- 
tracellular CAMP levels [ 11,16]. Furthermore, in 
many studies the accumuIation of adenosine, an 
agent that lowers CAMP levels, has not been con- 
trolled. In light of these problems, an alternate ap- 
proach was undertaken to determine the require- 
ment of CAMP changes for the inhibition of 
lipolysis by insulin. 
If insulin were to act through decreases of 
CAMP concentrations, this could be accomplished 
through either adenylate cyclase inhibition or 
phosphodiesterase stimulation (it has been 
established that insulin does not affect the parti- 
tioning of CAMP across the plasma membranes 
[16,28]). Although early reports of inhibition of 
adenylate cyclase by insulin exist [2,3], confirma- 
tion of these reports has been difficult. To study 
the role of adenylate cyclase inhibition, adipocytes 
were depleted of functional CAMP using the 
adenylate cyclase inhibitor PIA as in [20]. PIA ef- 
fectively inhibited the generation of CAMP since in 
the presence of PIA the effects of the phosphodi- 
esterase inhibitor Ro 20-1’724 were negligible. 
Under these conditions which approximate an ade- 
nylate cyclase-deficient cell, insulin antagonized 
the lipolytic effects of exogenously added CAMP 
analogs which bypass adenylate cyclase. This clear- 
ly demonstrates that adenylate cyclase inhibition is 
not required for the antilipolytic effect of insulin. 
Phosphodiesterase activation by insulin has been 
consistently observed in a number of insulin- 
sensitive tissues including adipose tissue (see [29] 
and references therein), however, the role of this 
effect has been disputed (review, 1301). The 
phosphodiesterase inhibitor Ro 20-1724 did not af- 
fect the insulin antagonism of lipolysis stimulated 
by epinephrine ([24]; table 1) suggesting that 
phosphodiesterase activation is not required. Some 
investigators have had difficulty in obtaining this 
10 
result [1,13] because the responses to insulin were 
examined on maximally stimulated rates of 
lipolysis where insulin is ineffective because of the 
high intracellular CAMP concentrations 13 11. 
To test the hypothesis that phosphodiesterase 
activation is not required for insulin inhibition of 
lipolysis, 8-thiomethyl-CAMP and 8-thioisopropyl- 
CAMP, two phosphodiesterase-resistant analogs 
[25,26], were used. Evidence that these analogs 
were not hydrolysed in vivo was obtained by 
assessing the effects of phosphodiesterase inhibi- 
tion on lipolysis stimulated by these analogs in 
adipocytes depleted of functional CAMP. The best 
controlled studies have indicated that at submax- 
imally stimulated rates of lipolysis, these rates 
reflect intracellular CAMP concentrations well 
[ iO,l 1,16,23,32-341. Therefore, the observation 
that phosphodiesterase inhibition had no effect on 
the rate of lipolysis stimulated by either analogs is 
further confirmation that these analogs are not ap- 
preciably hydrolysed in the cell. In adipocytes 
depleted of endogenous CAMP, insulin antagon- 
ized the lipolytic effects of these analogs even in 
the presence of the phosphodiesterase inhibitor 
Ro 20-1724. This clearly represents conditions 
where the antilipolytic effect of insulin does not in- 
volve adenylate cyclase or phosphodiesterase ac- 
tion and hence CAMP changes. 
The dissociation of the antagonistic effects of in- 
sulin from changes in hormonally stimulated levels 
of CAMP agrees with similar observations in liver 
[35]. A potential site of insulin action under these 
conditions is the direct inhibition of the CAMP- 
dependent protein kinase as has been observed in 
liver [35,36] and muscle [37,38]. Lipolysis is 
regulated through the phosphorylation of a 
hormonally-sensitive lipase by CAMP-dependent 
protein kinase [39]. Insulin decreases the 
phosphorylation of the stimulated lipase 1401 
which may be accomplished through either an in- 
hibition of protein kinase activity or an increase of 
protein phosphatase activity. A postulated inhibi- 
tion of CAMP-dependent protein kinase could also 
account for an increase in protein phosphatase ac- 
tivity since in adipose tissue insulin has been shown 
to decrease the phosphorylation and activity of a 
protein phosphatase inhibitor which is controlled 
by CAMP-dependent protein kinase [41]. Further 
studies will be necessary to determine the validity 
of these mechanisms. 
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NOTE ADDED IN PROOF 
Mooney et al. [42] recently reported that insulin 
antogonized lipolysis stimulate by exogenous 
CAMP in digitonin permeabilized rat adipocytes, 
further supporting the hypothesis that insulin ac- 
tion does not require adenylate cyclase inhibition. 
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